Detalhe da pesquisa
1.
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
Am J Hematol
; 99(4): 741-744, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279562
2.
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.
Am J Hematol
; 99(6): 1108-1118, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563187
3.
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
Am J Hematol
; 99(5): 1001-1004, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404143
4.
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.
Blood
; 138(21): 2142-2148, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945619
5.
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia
; 38(2): 326-339, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148396
6.
[An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown]. / Un exemple de réorganisation dans le fonctionnement d'un Centre d'investigations cliniques en période de confinement national suite à la pandémie COVID-19.
Therapie
; 76(4): 347-358, 2021.
Artigo
em Francês
| MEDLINE | ID: mdl-33640116